Heterogeneous distribution of Plasmodium falciparum drug resistance haplotypes in subsets of the host population

Malaria Journal

Volumn 7, Issue , 2008, Pages

  Schoepflin, Sonja ^a   Marfurt, Jutta ^a   Goroti, Mary ^b   Baisor, Moses ^b   Mueller, Ivo ^b   Felger, Ingrid ^a  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; ARTEMISININ DERIVATIVE; SESQUITERPENE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CHILD; CONTROLLED STUDY; DNA MICROARRAY; GENE LOCUS; GENE MUTATION; GENOTYPE; HAPLOTYPE; HOST; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MONOTHERAPY; PLASMODIUM FALCIPARUM; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; CROSS-SECTIONAL STUDY; DRUG EFFECT; DRUG RESISTANCE; GENETICS; MALARIA FALCIPARUM; PAPUA NEW GUINEA; PARASITOLOGY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RURAL POPULATION;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE; HAPLOTYPES; HUMANS; MALARIA, FALCIPARUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPUA NEW GUINEA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RURAL POPULATION; SESQUITERPENES;

EID: 44349123980     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-78     Document Type: Article

References (58)

1. Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine. Y Wu LA Kirkman TE Wellems, Proc Natl Acad Sci U S A 1996 93 1130 1134 8577727 10.1073/pnas.93.3.1130
2. Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria. T Triglia P Wang PF Sims JE Hyde AF Cowman, EMBO J 1998 17 3807 3815 9669998 10.1093/emboj/17.14.3807
3. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. AB Sidhu D Verdier-Pinard DA Fidock, Science 2002 298 210 213 10.1126/science.1074045 12364805
4. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. MB Reed KJ Saliba SR Caruana K Kirk AF Cowman, Nature 2000 403 906 909 10.1038/35002615 10706290
5. High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1. HA Babiker SJ Pringle A bdel-Muhsin M Mackinnon P Hunt D Walliker, J Infect Dis 2001 183 1535 1538 10.1086/320195 11319692
6. A molecular marker for chloroquine-resistant falciparum malaria. A Djimde OK Doumbo JF Cortese K Kayentao S Doumbo Y Diourte A Dicko XZ Su T Nomura DA Fidock TE Wellems CV Plowe D Coulibaly, N Engl J Med 2001 344 257 263 10.1056/NEJM200101253440403 11172152
7. Chloroquine-resistant malaria. TE Wellems CV Plowe, J Infect Dis 2001 184 770 776 10.1086/322858 11517439
8. Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from subsaharan Africa. LK Basco BJ Le Z Rhoades CM Wilson, Mol Biochem Parasitol 1995 74 157 166 10.1016/0166-6851(95)02492-1 8719157
9. Mutations in the pfmdr1, dhfr and dhps genes of Plasmodium falciparum are associated with in-vivo drug resistance in West Papua, Indonesia. HS Nagesha S Din GJ Casey AI Susanti DJ Fryauff JC Reeder AF Cowman, Trans R Soc Trop Med Hyg 2001 95 43 49 10.1016/S0035-9203(01)90329-3 11280065
10. Polymorphism of the Pfmdr1 gene and chloroquine resistance in Plasmodium falciparum in The Gambia. S L. MT Duraisingh CJ Drakeley R Bailey BM Greenwood M Pinder, Trans R Soc Trop Med Hyg 1997 91 450 453 10.1016/S0035-9203(97)90281-9 9373652
11. Sequence variations in the genes encoding dihydropteroate synthase and dihydrofolate reductase and clinical response to sulfadoxine-pyrimethamine in patients with acute uncomplicated falciparum malaria. LK Basco R Tahar A Keundjian P Ringwald, J Infect Dis 2000 182 624 628 10.1086/315731 10915101
12. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. JG Kublin FK Dzinjalamala DD Kamwendo EM Malkin JF Cortese LM Martino RA Mukadam SJ Rogerson AG Lescano ME Molyneux PA Winstanley P Chimpeni TE Taylor CV Plowe, J Infect Dis 2002 185 380 388 10.1086/338566 11807721
13. Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites. AM Nzila EK Mberu J Sulo H Dayo PA Winstanley CH Sibley WM Watkins, Antimicrob Agents Chemother 2000 44 991 996 10722502 10.1128/AAC.44.4.991-996.2000
14. Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria. AO Talisuna A Nalunkuma-Kazibwe P Langi TK Mutabingwa WW Watkins ME Van TG Egwang U D'Alessandro, Infect Genet Evol 2004 4 321 327 10.1016/j.meegid.2004.04.002 15374529
15. Intensity of malaria transmission and the evolution of drug resistance. IM Hastings WM Watkins, Acta Trop 2005 94 218 229 15847846
16. Gametocytocidal activity in antimalarial drugs speeds the spread of drug resistance. IM Hastings, Trop Med Int Health 2006 11 1206 1217 10.1111/j.1365-3156.2006.01668.x 16903884
17. Epidemiological models for the spread of anti-malarial resistance. JC Koella R Antia, Malar J 2003 2 3 12643812 10.1186/1475-2875-2-3
18. Act now or later? Economics of malaria resistance. R Laxminarayan, Am J Trop Med Hyg 2004 71 187 195 15331837
19. Survival probability of drug resistant mutants in malaria parasites. MJ Mackinnon, Proc Biol Sci 1997 264 53 59 9061960 10.1098/rspb.1997.0008
20. The evolution of multiple drug resistance in malaria parasites. MJ Mackinnon IM Hastings, Trans R Soc Trop Med Hyg 1998 92 188 195 10.1016/S0035-9203(98)90745-3 9764331
21. Multigenic drug resistance among inbred malaria parasites. C Dye BG Williams, Proc Biol Sci 1997 264 61 67 9061961 10.1098/rspb.1997.0009
22. Plasmodium falciparum infection dynamics and transmission potential following treatment with sulfadoxine-pyrimethamine. ML Gatton Q Cheng, J Antimicrob Chemother 2006 58 47 51 16641113 10.1093/jac/dkl158
23. Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine. V Robert HP wono-Ambene JY Le Hesran JF Trape, Am J Trop Med Hyg 2000 62 210 216 10813475
24. (Sub)microscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate. P Schneider T Bousema S Omar L Gouagna P Sawa H Schallig R Sauerwein, Int J Parasitol 2006 36 403 408 10.1016/j.ijpara.2006.01.002 16500657
25. Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs. A Sowunmi BA Fateye, Trop Med Int Health 2003 8 783 792 10.1046/j.1365-3156.2003.01093.x 12950664
26. Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. G Targett C Drakeley M Jawara SL von R Coleman J Deen M Pinder T Doherty C Sutherland G Walraven P Milligan, J Infect Dis 2001 183 1254 1259 10.1086/319689 11262208
27. Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria. S L. M Jawara R Coleman T Doherty G Walraven G Targett, Trop Med Int Health 2001 6 92 98 10.1046/j.1365-3156.2001.00683.x 11251903
28. Infectivity of Plasmodium falciparum gametocytes to Anopheles arabiensis after treatment with sulfadoxine-pyrimethamine. JM Govere DN Durrheim NM Mngomezulu K Barnes B Sharp, Trans R Soc Trop Med Hyg 2003 97 707 708 10.1016/S0035-9203(03)80108-6 16117968
29. Molecular analysis of Plasmodium falciparum from drug treatment failure patients in Papua New Guinea. GJ Casey M Ginny M Uranoli I Mueller JC Reeder B Genton AF Cowman, Am J Trop Med Hyg 2004 70 251 255 15031512
30. Rapid selection of dhfr mutant allele in Plasmodium falciparum isolates after the introduction of sulfadoxine/pyrimethamine in combination with 4-aminoquinolines in Papua New Guinea. T Mita A Kaneko I Hwaihwanje T Tsukahara N Takahashi H Osawa K Tanabe T Kobayakawa A Bjorkman, Infect Genet Evol 2006 6 447 452 10.1016/j.meegid.2006.02.004 16600696
31. Plasmodium falciparum: distribution of msp2 genotypes among symptomatic and asymptomatic individuals from the Wosera region of Papua New Guinea. A Cortes M Mellombo A Benet K Lorry L Rare JC Reeder, Exp Parasitol 2004 106 22 29 10.1016/j.exppara.2004.01.010 15013785
32. Plasmodium falciparum: extensive polymorphism in merozoite surface antigen 2 alleles in an area with endemic malaria in Papua New Guinea. I Felger L Tavul S Kabintik V Marshall B Genton M Alpers HP Beck, Exp Parasitol 1994 79 106 116 10.1006/expr.1994.1070 7914494
33. Mating patterns in malaria parasite populations of Papua New Guinea. RE Paul MJ Packer M Walmsley M Lagog LC Ranford-Cartwright R Paru KP Day, Science 1995 269 1709 1711 10.1126/science.7569897 7569897
34. The risk of malarial infections and disease in Papua New Guinean children. P Michon JL Cole-Tobian E Dabod S Schoepflin J Igu M Susapu N Tarongka PA Zimmerman JC Reeder JG Beeson L Schofield CL King I Mueller, Am J Trop Med Hyg 2007 76 997 1008 17556601
35. Diagnosing infection levels of four human malaria parasite species by a polymerase chain reaction/ligase detection reaction fluorescent microsphere-based assay. DT McNamara LJ Kasehagen BT Grimberg J Cole-Tobian WE Collins PA Zimmerman, Am J Trop Med Hyg 2006 74 413 421 16525099
36. Genotyping of Plasmodium falciparum. PCR-RFLP analysis. I Felger HP Beck, Methods Mol Med 2002 72 117 129 12125107
37. Distinction of recrudescences from new infections by PCR-RFLP analysis in a comparative trial of CGP 56 697 and chloroquine in Tanzanian children. A Irion I Felger S Abdulla T Smith R Mull M Tanner C Hatz HP Beck, Trop Med Int Health 1998 3 490 497 10.1046/j.1365-3156.1998.00253.x 9657512
38. Genotyping of Plasmodium spp. Nested PCR. G Snounou, Methods Mol Med 2002 72 103 116 12125106
39. Rapid microarray-based method for monitoring of all currently known single-nucleotide polymorphisms associated with parasite resistance to antimalaria drugs. A Crameri J Marfurt K Mugittu N Maire A Regos JY Coppee O Sismeiro R Burki E Huber D Laubscher O Puijalon B Genton I Felger HP Beck, J Clin Microbiol 2007 45 3685 3691 17804664 10.1128/JCM.01178-07
40. Comparison of PCR-RFLP and Genescan-based genotyping for analyzing infection dynamics of Plasmodium falciparum. N Falk N Maire W Sama S Owusu-Agyei T Smith HP Beck I Felger, Am J Trop Med Hyg 2006 74 944 950 16760501
41. Distribution of survival times of deliberate Plasmodium falciparum infections in tertiary syphilis patients. W Sama K Dietz T Smith, Trans R Soc Trop Med Hyg 2006 100 811 816 10.1016/j.trstmh.2005.11.001 16451806
42. The epidemiology of malaria in Papua New Guinea. I Muller M Bockarie M Alpers T Smith, Trends Parasitol 2003 19 253 259 10.1016/S1471-4922(03)00091-6 12798082
43. Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum. S Dunyo P Milligan T Edwards C Sutherland G Targett M Pinder, PLoS Clin Trials 2006 1 e20 17013431 10.1371/journal.pctr.0010020
44. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum. KI Barnes NJ White, Acta Trop 2005 94 230 240 15878154
45. Guidelines for the treatment of malaria. WHO, 2006
46. Measurement of malarial infectivity of human populations to mosquitoes in the Madang area, Papua, New Guinea. PM Graves TR Burkot R Carter JA Cattani M Lagog J Parker BJ Brabin FD Gibson DJ Bradley MP Alpers, Parasitology 1988 96 ( Pt 2) 251 263 3374964
47. Relationships between host infectivity to mosquitoes and asexual parasite density in Plasmodium falciparum. A Ross G Killeen T Smith, Am J Trop Med Hyg 2006 75 32 37 16931813
48. Age-dependent carriage of multiple Plasmodium falciparum merozoite surface antigen-2 alleles in asymptomatic malaria infections. F Ntoumi H Contamin C Rogier S Bonnefoy JF Trape O Mercereau-Puijalon, Am J Trop Med Hyg 1995 52 81 88 7856831
49. Age dependence of the multiplicity of Plasmodium falciparum infections and of other malariological indices in an area of high endemicity. T Smith HP Beck A Kitua S Mwankusye I Felger N Fraser-Hurt A Irion P Alonso T Teuscher M Tanner, Trans R Soc Trop Med Hyg 1999 93 Suppl 1 15 20 10.1016/S0035-9203(99) 90322-X 10450421
50. Molecular epidemiology of Plasmodium falciparum infections among asymptomatic inhabitants of a holoendemic malarious area in northern Ghana. S Owusu-Agyei T Smith HP Beck L menga-Etego I Felger, Trop Med Int Health 2002 7 421 428 10.1046/j.1365-3156.2002.00881.x 12000651
51. Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum. ME Osman FP Mockenhaupt U Bienzle MI Elbashir HA Giha, Infect Genet Evol 2007 7 52 59 10.1016/j.meegid.2006.03.008 16690361
52. The impact of antimalarial drug resistance mutations on parasite fitness, and its implications for the evolution of resistance. IM Hastings MJ Donnelly, Drug Resist Updat 2005 8 43 50 10.1016/j.drup.2005.03.003 15939341
53. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. JG Kublin JF Cortese EM Njunju RA Mukadam JJ Wirima PN Kazembe AA Djimde B Kouriba TE Taylor CV Plowe, J Infect Dis 2003 187 1870 1875 10.1086/375419 12792863
54. Fitness of drug-resistant malaria parasites. D Walliker P Hunt H Babiker, Acta Trop 2005 94 251 259 15845348
55. Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People's Republic of China. X Wang J Mu G Li P Chen X Guo L Fu L Chen X Su TE Wellems, Am J Trop Med Hyg 2005 72 410 414 15827277
56. Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites. R Ord N Alexander S Dunyo R Hallett M Jawara G Targett CJ Drakeley CJ Sutherland, J Infect Dis 2007 196 1613 1619 10.1086/522154 18008244
57. Drug resistant Plasmodium falciparum in an area of seasonal transmission. HA Babiker G Satti H Ferguson R Bayoumi D Walliker, Acta Trop 2005 94 260 268 15857801
58. Return of chloroquine antimalarial efficacy in Malawi. MK Laufer PC Thesing ND Eddington R Masonga FK Dzinjalamala SL Takala TE Taylor CV Plowe, N Engl J Med 2006 355 1959 1966 10.1056/NEJMoa062032 17093247